News | Artificial Intelligence | August 19, 2019

Lunit Receives Korea MFDS Approval for Lunit Insight MMG

Artificial intelligence-based breast cancer detection solution aims to improve effectiveness of mammography screening and reduce unnecessary biopsies

Lunit Receives Korea MFDS Approval for Lunit Insight MMG

August 19, 2019 — Lunit has announced Korea Ministry of Food and Drug Safety (MFDS) approval of its artificial intelligence (AI) solution for breast cancer, Lunit Insight MMG. The announcement marks the second approval of its AI solution by Korea MFDS since 2018, when Lunit had gained initial regulatory clearance of its AI software.

Lunit Insight MMG, which is now available for domestic sales in Korea, runs on Lunit’s proprietary AI technology, co-developed with Korean medical institutions including Yonsei Severance Hospital, Asan Medical Center and Samsung Medical Center. 

The software analyzes mammography images, with an indication of the location of lesions suspicious for breast cancer and an abnormality score of the detected lesion.

According to Lunit CEO Brandon Suh, breast cancer is one of the most common female cancer, taking up to 24 percent of all female cancer cases. He added that among the patients suspicious of breast cancer after screening mammography, only 29 percent are actually diagnosed with cancer after biopsy.

Suh said that the company is using AI to increase the effectiveness of mammography screening and reduce unnecessary biopsies. According to the company, the algorithm is designed to assist prompt and accurate diagnosis by physicians, by showing only malignant lesions and automatically ignoring benign lesions. It has been trained with more than 200,000 mammography cases, which includes 50,000 breast cancer cases.

Lunit provides an online demo for users to test the performance of its software. 

The company had previously received MFDS clearance in August 2018 for its AI solution for chest X-ray. The software is currently being used at multiple hospitals and medical examination centers throughout the country, including Seoul National University Hospital.

For more information: www.lunit.io

Related Content

The study finds it's possible to use commercial facial recognition software to identify people from brain MRI that includes imagery of the face
News | Magnetic Resonance Imaging (MRI) | November 15, 2019
November 15, 2019 — Though identifying data typically are removed from medical image files before they are shared for
Image by Pexels from Pixabay RSNA 2019

Image by Pexels from Pixabay 

News | RSNA | November 15, 2019
November 15, 2019 – The 105th Scientific Assembly and Annual Meeting of the...
EchoGo uses artificial intelligence (AI) to calculate cardiac ultrasound left ventricular ejection fraction (EF), the most frequently used measurement of heart function, left ventricular volumes (LV) and, for the first time for an AI application, automated cardiac strain.

EchoGo uses artificial intelligence (AI) to calculate cardiac ultrasound left ventricular ejection fraction (EF), the most frequently used measurement of heart function, left ventricular volumes (LV) and, for the first time for an AI application, automated cardiac strain.

News | Cardiovascular Ultrasound | November 14, 2019
November 14, 2019 — Ultromics has received 510(k) clearance from the U.S.

Guerbet presented its Contrast&Care injection management solution at ECR 2018

News | Contrast Media | November 13, 2019
November 13, 2019 – Guerbet, a global specialist in...
Mindray announced its partnership with Cincinnati Children's Hospital Medical Center, one of the top children's hospitals in the United States
News | Ultrasound Imaging | November 13, 2019
November 13, 2019 – Mindray announced its partnership with...
 MaxQ AI
News | Artificial Intelligence | November 13, 2019
November 13, 2019 – MaxQ AI announced a new partnership agreement with...
 Paxera Ultima 360
News | Enterprise Imaging | November 12, 2019
November 12, 2019 — Medical Imaging developer PaxeraHealth will showcase the